김성은 교수
전문진료분야
지방간,간염,간경변,간암
전화 예약
1577-1801
기본정보
학력
2008.03 ~ 2010.02울산대학교 대학원 박사 2005.03 ~ 2007.02한림대학교 대학원 석사 1996.03 ~ 2002.02한림대학교 의과대학 학사 |
경력
한림대학교성심병원 소화기내과 교수 한림대학교 의과대학 내과 부교수 UCSD (University of California San Diego) Visiting Scholar 한림대학교 의과대학 내과 조교수 한림대학교 의과대학 내과 부교수 한림대학교 의과내학 의학교육학 겸임교수 서울의료원 소화기내과 촉탁전문의 서울아산병원 소화기내과 전임의 |
학회활동
대한간암학회 정회원 (전) 대한간암학회 보험위원회 위원 대한소화기내시경학회 정회원 대한간학회 의료정책위원회 위원 대한내과학회 정회원 대한소화기학회 정회원 유럽간학회 정회원 한국의료시뮬레이션학회 정회원 대한간학회 2019 간경변증 가이드라인 편집위원 대한간학회 정회원 아시아태평양간학회 정회원 대한간암학회 교육이사 대한 간학회 알코올연구회 학술이사 한국호스피스완화의료학회 무임소이사 |
수상이력
2017보건복지부 장관 표창 2012유럽간학회 (EASL) Young investigator award Top 10% 2008아시아태평양간학회 (APASL) Young investigator award |
논문
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs (Journal of viral hepatitis)
Real-world Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome (Clinical Gastroenterology and Hepatology)
Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study (Medicina (Kaunas))
Impact of metabolic dysfunction on treatment responses to$$nucleos(t)ide analogues in chronic hepatitis B: a retrospective$$multi-center REAL-B cohort study (eClinicalMedicine)
Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues (CLINICAL AND MOLECULAR HEPATOLOGY)
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study (LANCET GASTROENTEROLOGY & HEPATOLOGY)
High cellular prion protein expression in cholangiocarcinoma: A$$marker for early postoperative recurrence and unfavorable$$prognosis (World Journal of gastrointestinal surgery)
Aetiology of chronic liver disease is a valuable$$factor for stratifying adverse outcomes of acute$$decompensation: prospective observational study (Annals of Medicine)
Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis (LIVER INTERNATIONAL)
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation (HEPATOLOGY INTERNATIONAL)
Real-world Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome (Clinical Gastroenterology and Hepatology)
Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study (Medicina (Kaunas))
Impact of metabolic dysfunction on treatment responses to$$nucleos(t)ide analogues in chronic hepatitis B: a retrospective$$multi-center REAL-B cohort study (eClinicalMedicine)
Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues (CLINICAL AND MOLECULAR HEPATOLOGY)
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study (LANCET GASTROENTEROLOGY & HEPATOLOGY)
High cellular prion protein expression in cholangiocarcinoma: A$$marker for early postoperative recurrence and unfavorable$$prognosis (World Journal of gastrointestinal surgery)
Aetiology of chronic liver disease is a valuable$$factor for stratifying adverse outcomes of acute$$decompensation: prospective observational study (Annals of Medicine)
Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis (LIVER INTERNATIONAL)
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation (HEPATOLOGY INTERNATIONAL)